DK0644196T3 - TTTr som beskyttelsesgruppe i nucleotidsyntesen - Google Patents

TTTr som beskyttelsesgruppe i nucleotidsyntesen

Info

Publication number
DK0644196T3
DK0644196T3 DK94810522T DK94810522T DK0644196T3 DK 0644196 T3 DK0644196 T3 DK 0644196T3 DK 94810522 T DK94810522 T DK 94810522T DK 94810522 T DK94810522 T DK 94810522T DK 0644196 T3 DK0644196 T3 DK 0644196T3
Authority
DK
Denmark
Prior art keywords
tttr
protecting group
nucleotide synthesis
nucleotides
nucleosides
Prior art date
Application number
DK94810522T
Other languages
English (en)
Inventor
Wolfgang K D Dr Brill
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0644196T3 publication Critical patent/DK0644196T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94810522T 1993-09-17 1994-09-08 TTTr som beskyttelsesgruppe i nucleotidsyntesen DK0644196T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH281393 1993-09-17

Publications (1)

Publication Number Publication Date
DK0644196T3 true DK0644196T3 (da) 1998-07-27

Family

ID=4242181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94810522T DK0644196T3 (da) 1993-09-17 1994-09-08 TTTr som beskyttelsesgruppe i nucleotidsyntesen

Country Status (13)

Country Link
US (1) US5639867A (da)
EP (1) EP0644196B1 (da)
JP (1) JPH07165787A (da)
KR (1) KR950008530A (da)
CN (1) CN1111249A (da)
AT (1) ATE159949T1 (da)
AU (1) AU671387B2 (da)
CA (1) CA2132133A1 (da)
DE (1) DE59404522D1 (da)
DK (1) DK0644196T3 (da)
ES (1) ES2110726T3 (da)
IL (1) IL110968A0 (da)
ZA (1) ZA947180B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701219D0 (sv) * 1997-04-04 1997-04-04 Astra Pharma Prod New compounds
WO1998047910A1 (en) * 1997-04-21 1998-10-29 Proligo Llc Method for solution phase synthesis of oligonucleotides
US6414137B1 (en) * 1998-12-23 2002-07-02 Alliedsignal Inc. Selective solvent extraction for the purification of protected nucleosides
CA2370478A1 (en) 1999-03-24 2000-09-28 Serge L. Beaucage N-acylphosphoramidites and their use in oligonucleotide synthesis
DE60201145T2 (de) * 2001-05-15 2005-09-22 Mitsui Chemicals, Inc. Verfahren zur Reinigung von 5'-geschützten Thymidinen
AU2002353001A1 (en) * 2001-12-03 2003-06-17 The Government Of The United States Of America, Represented By The Secretary Of The Department Of He Thermolabile hydroxyl protecting groups and methods of use
US7002006B2 (en) * 2003-02-12 2006-02-21 Isis Pharmaceuticals, Inc. Protection of nucleosides
US9809824B2 (en) * 2004-12-13 2017-11-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
CN102344477B (zh) * 2010-07-27 2015-04-08 苏州瑞博生物技术有限公司 一种核苷酸和/或寡核苷酸及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW323284B (da) * 1992-03-23 1997-12-21 Novartis Ag

Also Published As

Publication number Publication date
EP0644196B1 (de) 1997-11-05
US5639867A (en) 1997-06-17
DE59404522D1 (de) 1997-12-11
IL110968A0 (en) 1994-11-28
ZA947180B (en) 1995-03-17
ES2110726T3 (es) 1998-02-16
CA2132133A1 (en) 1995-03-18
JPH07165787A (ja) 1995-06-27
EP0644196A1 (de) 1995-03-22
AU7304394A (en) 1995-03-30
CN1111249A (zh) 1995-11-08
ATE159949T1 (de) 1997-11-15
AU671387B2 (en) 1996-08-22
KR950008530A (ko) 1995-04-19

Similar Documents

Publication Publication Date Title
ATE167803T1 (de) Hemmung der replikation des influenza-virus durch oligonukleotide
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
TW377356B (en) Process for purifying and isolating beta-anomer enriched 2'-deoxy-2',2'-difluoronucleosides
PT775149E (pt) Novos grupos de proteccao e a sua utilizacao num processo melhorado para a sintese de oligonucleotidos
CA2279932A1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
ATE299509T1 (de) Neue 2'-o-alkyl-nukleoside und -phosphoramidite, verfahren zu ihrer herstellung und ihre verwendungen
FI104176B1 (fi) Menetelmä nukleosidien uusien antiviraalisten forfolipidijohdannaisten valmistamiseksi
CA2144477A1 (en) Pna synthesis using an amino protecting group which is labile to weak acids
NO308343B1 (no) Katalysatorblanding eller reaktantblanding, samt fremgangsmÕte for utførelse av kjemiske reaksjoner
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
WO1997040458A3 (en) Universal solid supports and methods for their use
CA2088363A1 (en) Process for the preparation of nucleotides
DK0644196T3 (da) TTTr som beskyttelsesgruppe i nucleotidsyntesen
EP0877014A3 (en) Diaminoalkylene quaternary ammonium salts, method for their preparation and use
AU4848793A (en) Oligonucleotide and nucleotide amine analogs, methods of synthesis and use
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
NO962006L (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
ES8603893A1 (es) Procedimiento de desalquilacion de alcaloides e intermedia- rios
DE69612024D1 (de) Verfahren zur Herstellung von 1-(2'-Desoxy-2',2'-difluoro-d-ribo-pentofuranosyl)-cytosin aus 2-Desoxy-2,2-difluoro-beta-d-ribo-pentopyranose
ATE61577T1 (de) Fluorierte abkoemmlinge von vitamin-d3 und verfahren zu deren herstellung.
ITMI913381A0 (it) Processo per formare alluminuro di titanio contenente cromo, tantalio e boro
NO962999D0 (no) Fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum, såvel som medikament inneholdende dem
EP0234494A3 (en) Isohexide nucleosides, processes for their preparation and their use as medicaments
PT98963A (pt) Processo para a preparacao de compostos intermediarios para a sintese quimica de oligonucleotidos e para a preparacao de derivados de nucleosidos, de nucleotidos e de oligonucleotidos, utilizado esses intermediarios
CA2187849A1 (en) Uck14 compounds